HCA Healthcare (NYSE: HCA) is a leading hospital operator in the healthcare sector. The company's primary activities involve providing a comprehensive range of medical care services through its extensive network of facilities. Its performance often reflects broader trends within the healthcare services industry.
On April 24, 2026, HCA Healthcare reports its first-quarter results, revealing an earnings per share (EPS) of $7.15. This figure surpasses the analyst consensus estimate of $7.12. The EPS also represents a 10.9 percent increase from the $6.45 reported in the same quarter of the previous year.
The company also announces revenue of $19.11 billion, which exceeds the consensus estimate of $19.09 billion. This revenue figure marks a 4.3 percent increase compared to the first quarter of 2025. Strong demand for its medical care services supports this revenue growth, as highlighted by Reuters.
Operationally, HCA Healthcare's performance shows positive momentum. The company sees a 0.9 percent rise in same-facility admissions and a significant 22 percent jump in cash flows from operating activities to over $2 billion. This indicates strong cash generation from its core business.
From a valuation standpoint, HCA Healthcare has a Price-to-Earnings (P/E) ratio of 14.78. This ratio suggests investors are willing to pay $14.78 for every dollar of the company's earnings. The company's current ratio is 0.80, which measures its ability to meet short-term obligations with its current assets.
